Media Summary: Presented by Xin Bu, Principal Scientist at Bristol-Myers Squibb. www.simulations-plus.com Physiologically-based pharmacokinetic (PBPK) simulations require parameterization based on in ... Recorded November 17, 2022 Wayne Matthews. Principal Investigator R&D, Drug Substance Development Materials Science UK ...
Using In Vitro Dissolution To - Detailed Analysis & Overview
Presented by Xin Bu, Principal Scientist at Bristol-Myers Squibb. www.simulations-plus.com Physiologically-based pharmacokinetic (PBPK) simulations require parameterization based on in ... Recorded November 17, 2022 Wayne Matthews. Principal Investigator R&D, Drug Substance Development Materials Science UK ... Simulations Plus provides powerful science to help you make faster and more informed project decisions. Model and simulate the ... At the BASF Solubilization Symposium Dr. Frank Romanski talks about biorelevant DDDPlus is a state-of-the-art simulation platform for in
In Vitro: Dissolution and Drug Release Testing Comparing Spectroscopy Measurements in the Prediction of in Bioequivalence (BE) trials are used to show that a new treatment is identical (within an acceptable range) to a current treatment.
